An evaluation of the effectiveness of different techniques for intraoperative infiltration of antibiotics into alloplastic implants for use in facial reconstruction.
BACKGROUND
Reconstruction in the head and neck can be difficult owing to the size of the defect or characteristics of the tissue that needs to be replaced. Facial wounds or reconstruction sites can be subject to contamination, thereby risking infection of any implanted material even under ideal circumstances. Particular areas of concern are sites where minimizing the bacterial contamination prior to placing an implant is difficult (eg, the oral cavity and internal nose). Reconstruction involves the facial subcutaneous soft tissue and/or bone, and the ideal implant provides support and natural feel, as well as a low risk of infection. The biocompatibility of alloplastic implants depends on the tissue inertness of the implant and the porosity, allowing connective tissue ingrowth, which in turn decreases the susceptibility to infection. Scalafani et al demonstrated that alloplastic implants contaminated prior to fibrovascular ingrowth had a much higher incidence of infection and rejection.


OBJECTIVE
To examine the effectiveness of several techniques for infiltrating antibiotics into alloplastic implants of different porosity using 2 commonly used alloplastic implants, expanded polytetrafluoroethylene (e-PTFE, or GORE-TEX) and porous high-density polyethylene (Medpor).


RESULTS
Using an in vitro bacterial growth inhibition model, we found that suction infiltration of the implant with antibiotics was the most effective technique, with a statistically significant advantage over other techniques used. The advantages of the suction impregnation were seen to be most effective using alloplasts with a smaller pore size (20-30 microm) (P < .001), but there was a statistically significant difference even with implants with a larger pore size (150-200 microm) (P < .001).


CONCLUSIONS
Suction infiltration of antibiotics into porous implants seems to be the most effective method identified using an in vitro testing protocol. Further experiments will be needed to confirm the effectiveness in reducing the perioperative risk of infection in vivo.
Keefe
Morgan S
MS
Science Division, Our Lady of Peace Academy, San Diego, California, USA.
Keefe
Michael A
MA
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001672:Biocompatible Materials; D016503:Drug Delivery Systems; D005145:Face / Q000601:surgery; D006801:Humans; D066298:In Vitro Techniques; D007430:Intraoperative Care / Q000379:methods; D008422:Materials Testing; D011095:Polyethylenes / Q000737:chemistry; D011138:Polytetrafluoroethylene / Q000737:chemistry; D019736:Prostheses and Implants; D016459:Prosthesis-Related Infections / Q000517:prevention & control; D019651:Plastic Surgery Procedures / Q000009:adverse effects / Q000379:methods; D012680:Sensitivity and Specificity; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D001672:Biocompatible Materials; C084562:Medpor; D011095:Polyethylenes; D011138:Polytetrafluoroethylene